$111.890
-2.014 (-1.80%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MNPR Prediction & Forecast by Similar Chart Analysis
Alphio's MNPR stock price prediction model matches the current Monopar Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $112.14 (+0.22%). The 1-week path is $114.62 (+2.44%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Monopar Therapeutics Inc Stock?
Monopar Therapeutics Inc is a good buy right now due to its recent stock price of $111.89, which is significantly lower than the analyst price target of $133 from BTIG. The company has shown a remarkable year-to-date change of +69.50% and a one-year change of +229.77%, indicating strong momentum. However, the main risk is the negative net income reported for Q2 2026, which was -5,313,300 USD, suggesting ongoing financial challenges that investors should monitor closely.
MNPR stock price ended at $111.89 on Friday, after losing -1.80%
Monopar Therapeutics Inc (MNPR) last closed at $111.89, losing -1.80%. These facts feed the 1-day and 1-week MNPR price prediction above.
Forecast Drivers
Monopar Therapeutics Inc (MNPR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches MNPR, ranked by similarity.
Seasonality analysis for MNPR
Historically the probability of a positive August return for MNPR is 100.00%. July offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MNPR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $47.43 | $48.43 | $55.92 | -56.71% |
| Sep 2026 | $45.38 | $49.94 | $52.77 | -55.37% |
| Oct 2026 | $49.44 | $49.76 | $51.59 | -55.52% |
| Nov 2026 | $37.98 | $45.86 | $55.22 | -59.02% |
| Dec 2026 | $33.98 | $42.59 | $43.27 | -61.94% |
In 2026, Monopar Therapeutics Inc (MNPR) is projected to range from $33.98 to $55.92.
Monopar Therapeutics Inc 2026 monthly forecast
In Aug 2026, Monopar Therapeutics Inc is projected to average $48.43, with a low of $47.43 and high of $55.92.
In Sep 2026, Monopar Therapeutics Inc is projected to average $49.94, with a low of $45.38 and high of $52.77.
In Oct 2026, Monopar Therapeutics Inc is projected to average $49.76, with a low of $49.44 and high of $51.59.
In Nov 2026, Monopar Therapeutics Inc is projected to average $45.86, with a low of $37.98 and high of $55.22.
In Dec 2026, Monopar Therapeutics Inc is projected to average $42.59, with a low of $33.98 and high of $43.27.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.